Literature DB >> 24164657

Late development of complete atrioventricular block may be immune mediated and congenital in origin.

Gunnar Bergman1, Amanda Skog, Joanna Tingström, Vijole Ottosson, Ariela Hoxha, Aurelie Ambrosi, Stina Salomonsson, Marie Wahren-Herlenius.   

Abstract

AIM: To investigate the correlation between maternal autoantibodies and age at diagnosis of isolated complete atrioventricular (AV) block (CAVB) and to study signs of late progression of foetal immune-mediated insults in cases of postnatally diagnosed CAVB.
METHODS: Patients with CAVB (n = 190) identified in a population-based manner were included. Maternal autoantibody profile was correlated with age at CAVB diagnosis. A structured review of medical records was performed if a late CAVB diagnosis (>27 days post-partum) was associated with a sero-positive mother.
RESULTS: Maternal Ro/La autoantibodies were observed in 88% of cases with a congenital diagnosis. Thirteen cases with a sero-positive mother and late CAVB diagnosis were found (age-range: 4 months-43 years). In two cases, CAVB was diagnosed in conjunction with infections, one case had a family history of cardiomyopathy and two cases had nontypical clinical presentations, indicating alternative pathogenetic mechanisms. In the remaining eight cases, no likely factors inducing CAVB, other than maternal autoantibodies, could be identified.
CONCLUSION: Our observations support the hypothesis that late progression to CAVB can be the result of an immune-mediated pathogenetic mechanism during foetal life. An autoantibody-associated diagnosis after the neonatal period is therefore possible, and testing of maternal serology at the time of diagnosis is recommended. ©2013 Foundation Acta Paediatrica. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Autoantibodies; Congenital heart block; Late progression; Neonatal lupus erythematosus; SSA; SSB

Mesh:

Substances:

Year:  2013        PMID: 24164657     DOI: 10.1111/apa.12483

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  5 in total

1.  Serum Biomarkers of Inflammation, Fibrosis, and Cardiac Function in Facilitating Diagnosis, Prognosis, and Treatment of Anti-SSA/Ro-Associated Cardiac Neonatal Lupus.

Authors:  Amit Saxena; Peter M Izmirly; Sung Won Han; Paraskevi Briassouli; Tania L Rivera; Hua Zhong; Deborah M Friedman; Robert M Clancy; Jill P Buyon
Journal:  J Am Coll Cardiol       Date:  2015-08-25       Impact factor: 24.094

Review 2.  Neonatal Lupus: What We Have Learned and Current Approaches to Care.

Authors:  Marisa S Klein-Gitelman
Journal:  Curr Rheumatol Rep       Date:  2016-09       Impact factor: 4.592

3.  Diagnostic and Management Difficulties of Complete Atrioventricular Block In Children in Marrakech: A Report of Three Cases With a Review of the Literature.

Authors:  Mounia Khramaz; Salwa Elkarimi; Dounia Benzerroual; Mustapha Elhattaoui; Fahd Aboutofail; Drissi Boumzebra; Rachid Elhaouati
Journal:  J Atr Fibrillation       Date:  2016-08-31

Review 4.  Congenital and childhood atrioventricular blocks: pathophysiology and contemporary management.

Authors:  Alban-Elouen Baruteau; Robert H Pass; Jean-Benoit Thambo; Albin Behaghel; Solène Le Pennec; Elodie Perdreau; Nicolas Combes; Leonardo Liberman; Christopher J McLeod
Journal:  Eur J Pediatr       Date:  2016-06-28       Impact factor: 3.183

5.  Isolated atrioventricular block of unknown origin in the adult and autoimmunity: diagnostic and therapeutic considerations exemplified by 3 anti-Ro/SSA-associated cases.

Authors:  Pietro Enea Lazzerini; Antonio Brucato; Pier Leopoldo Capecchi; Lucia Baldi; Maria Romana Bacarelli; Claudia Nucci; Valentina Moscadelli; Gabriella Morozzi; Mohamed Boutjdir; Franco Laghi-Pasini
Journal:  HeartRhythm Case Rep       Date:  2015-06-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.